EA201600607A1 - Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани - Google Patents

Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани

Info

Publication number
EA201600607A1
EA201600607A1 EA201600607A EA201600607A EA201600607A1 EA 201600607 A1 EA201600607 A1 EA 201600607A1 EA 201600607 A EA201600607 A EA 201600607A EA 201600607 A EA201600607 A EA 201600607A EA 201600607 A1 EA201600607 A1 EA 201600607A1
Authority
EA
Eurasian Patent Office
Prior art keywords
creating
bone tissue
tissue regeneration
activated implant
personalized gene
Prior art date
Application number
EA201600607A
Other languages
English (en)
Other versions
EA033357B1 (ru
Inventor
Артур Александрович ИСАЕВ
Роман Вадимович ДЕЕВ
Илья Ядигерович БОЗО
Владимир Сергеевич КОМЛЕВ
Алексей Юрьевич ДРОБЫШЕВ
Original Assignee
Общество с ограниченной ответственностью "НекстГен"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "НекстГен" filed Critical Общество с ограниченной ответственностью "НекстГен"
Publication of EA201600607A1 publication Critical patent/EA201600607A1/ru
Publication of EA033357B1 publication Critical patent/EA033357B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00—Materials specially adapted for additive manufacturing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

Изобретение относится к медицине, а именно к созданию остеопластических материалов, эффективных в замещении протяженных (объемных) костных дефектов. Разработанный способ изготовления таких медицинских изделий включает применение технологий трехмерной печати биорезиорбируемых матриксов-носителей и их активации генными конструкциями. Полученные таким способом медицинские изделия могут составить эффективную альтернативу костным аутотрансплантатам.
EA201600607A 2015-02-10 2015-10-13 Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани EA033357B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2015104291/15A RU2597786C2 (ru) 2015-02-10 2015-02-10 Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани
PCT/RU2015/000667 WO2016130041A1 (ru) 2015-02-10 2015-10-13 Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани

Publications (2)

Publication Number Publication Date
EA201600607A1 true EA201600607A1 (ru) 2016-12-30
EA033357B1 EA033357B1 (ru) 2019-10-31

Family

ID=56614923

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201600607A EA033357B1 (ru) 2015-02-10 2015-10-13 Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани

Country Status (11)

Country Link
US (1) US11406739B2 (ru)
EP (1) EP3130342B1 (ru)
JP (1) JP6631924B2 (ru)
CN (1) CN106488771B (ru)
BR (1) BR112016027050B1 (ru)
CA (1) CA2946389A1 (ru)
EA (1) EA033357B1 (ru)
ES (1) ES2714782T3 (ru)
MX (1) MX2016016081A (ru)
RU (1) RU2597786C2 (ru)
WO (1) WO2016130041A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018230675A1 (ja) * 2017-06-16 2018-12-20 国立大学法人九州大学 第八リン酸カルシウム成形体の製造方法
RU2688699C1 (ru) * 2018-01-22 2019-05-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ планирования операции синус-лифтинг
RU2683852C1 (ru) * 2018-01-22 2019-04-02 Общество с ограниченной ответственностью "Северо-Кавказское медицинское малое инновационное предприятие" Способ расчета объема костнозамещающего материала при планировании операции направленной регенерации костной ткани
RU2696204C1 (ru) * 2018-04-26 2019-07-31 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ расчёта площади барьерных и каркасных мембран при планировании направленной регенерации костной ткани
RU2726398C2 (ru) * 2018-08-08 2020-07-13 Федеральное государственное учреждение "Федеральный научно-исследовательский центр "Кристаллография и фотоника" Российской академии наук" (ФНИЦ "Кристаллография и фотоника" РАН) Способ изготовления имплантата позвонка анатомической формы из костного материала, совместимого с иммунной системой больного
US11090412B2 (en) 2018-12-21 2021-08-17 Zavation Medical Products Llc Bone repair composition and kit
RU2766978C1 (ru) * 2021-01-13 2022-03-16 Общество с ограниченной ответственностью "Медлайн Компани" Многокомпонентный остеогенный трансплантат для хирургического устранения врождённых и приобретённых дефектов кости челюстей
RU2764373C1 (ru) * 2021-03-29 2022-01-17 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ применения ген-активированного материала при несращениях длинных костей
CN116271222B (zh) * 2023-03-28 2023-12-01 广东医科大学 一种骨组织工程支架及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US8882847B2 (en) * 2001-05-25 2014-11-11 Conformis, Inc. Patient selectable knee joint arthroplasty devices
US7427602B1 (en) * 1998-05-13 2008-09-23 The Regents Of The University Of Michigan Sustained DNA delivery from structural matrices
WO2000021470A1 (en) * 1998-10-12 2000-04-20 Therics, Inc. Composites for tissue regeneration and methods of manufacture thereof
US6294187B1 (en) * 1999-02-23 2001-09-25 Osteotech, Inc. Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
CN101796186B (zh) * 2007-06-07 2013-05-22 韦克福里斯特大学健康科学院 喷墨基因打印
EP2442747A4 (en) * 2009-06-17 2016-11-09 Univ Columbia DENTAL BRACES
RU2519326C2 (ru) * 2011-12-29 2014-06-10 Общество с ограниченной ответственностью "НекстГен" Биокомпозит для обеспечения восстановительных процессов после повреждения у млекопитающего, способ его получения (варианты) и применения
US9089388B2 (en) * 2012-07-06 2015-07-28 Peter John Zegarelli Oral appliance for delivery of medicaments and/or other substances
US9925299B2 (en) * 2012-10-26 2018-03-27 Tufts University Silk-based fabrication techniques to prepare high strength calcium phosphate ceramic scaffolds
US20160095958A1 (en) * 2013-05-28 2016-04-07 The Johns Hopkins University Bone regeneration using stromal vascular fraction, platelet-derived growth factor-rich hydrogel, three-dimensional printed poly-epsilon-caprolactone scaffolds

Also Published As

Publication number Publication date
RU2597786C2 (ru) 2016-09-20
EP3130342A4 (en) 2017-04-12
JP6631924B2 (ja) 2020-01-15
WO2016130041A1 (ru) 2016-08-18
US20170209626A1 (en) 2017-07-27
CN106488771B (zh) 2019-12-17
ES2714782T3 (es) 2019-05-30
EP3130342B1 (en) 2018-12-12
RU2015104291A (ru) 2016-08-27
JP2018505701A (ja) 2018-03-01
EA033357B1 (ru) 2019-10-31
CN106488771A (zh) 2017-03-08
MX2016016081A (es) 2017-03-10
BR112016027050A2 (pt) 2019-11-12
BR112016027050B1 (pt) 2021-01-19
CA2946389A1 (en) 2016-08-18
US11406739B2 (en) 2022-08-09
EP3130342A1 (en) 2017-02-15

Similar Documents

Publication Publication Date Title
EA201600607A1 (ru) Способ создания персонализированного ген-активированного имплантата для регенерации костной ткани
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
CL2017001289A1 (es) Compuestos bicíclicos fusionados, sus composiciones y su uso para el tratamiento de enfermedades relacionadas con la modulación del receptor x farnesoide (fxr).
NZ749355A (en) Anti-tim-3 antibodies and methods of use thereof
CL2019000836A1 (es) Construcciones de inmunoglobulina heterodiméricas y métodos de preparación de las mismas.
BR112017012859A2 (pt) fosforamidatos para o tratamento do vírus da hepatite b
CL2018001569A1 (es) Compuestos heteroaromáticos como inhibidores de btk
BR112017004403A2 (pt) curativo médico
ZA201903105B (en) Methods for treating muscle wasting and bone disease using novel hybrid actriib ligand trap proteins
AR099462A1 (es) Unidad de ultrafiltración para el intercambio continuo de medio o tampón de una solución proteica
CL2015002121A1 (es) Modulares de receptores nmda de espiro-lactama y sus usos.
CL2015002122A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
BR112018004246A2 (pt) combinação que compreende oligonucleotídeos imunoestimulantes
CY1125552T1 (el) Μεθοδος για την παρασκευη ουσιαστικα διαστερεομερικως καθαρου φωσφοροδιαμιδικου ολιγομερους, φωσφοροδιαμιδικου ολιγομερους που παρασκευαζεται με τετοια μεθοδο και φαρμακευτικη συνθεση αποτελουμενη απο τετοιο φωσφοροδιαμιδικο ολιγομερες
CY1122615T1 (el) Θεραπεια με βλαστοκυτταρα σε παθολογιες τουενδομητριου
EA201790504A1 (ru) Монослой мононуклеарных клеток периферической крови или клеток костного мозга и его применение
ZA201805721B (en) Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods therefor
GB2567360A (en) Methods for optical micropatterning of hydrogels and uses thereof
DK3697459T3 (da) Autolog knogleimplantaterstatning
IL263664A (en) Methods to treat the disease using bmp6 inhibitors
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
CL2020000733A1 (es) Proteína de fusión que comprende una porción de fgf-18.
MX2015008944A (es) Proceso de liofilizacion.
PH12020550483A1 (en) Anti-apoc3 antibodies and methods of use thereof
CR20160444A (es) Proteínas de fusión uti

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): AM AZ BY KZ